{"id":"cbb9eca5-f3b7-4400-a536-a8b6c8b973f6","modelId":"a4a2491a-bfdd-4ba3-b370-771d234bc136","versionId":null,"locationId":"aa8b9c05-c836-4021-801f-59801970401e","operatorId":null,"ownerId":null,"slug":"ekso-nr-united-states","status":"active","firstSeen":null,"manufacturerSerial":null,"reviewStatus":"reviewed","sources":[{"url":"https://eksobionics.com/en/eksonr/","title":"EksoNR","sourceName":"Ekso Bionics"},{"url":"https://ir.chronoscale.com/press-releases/detail/729/ekso-bionics-receives-fda-clearance-to-market-its-eksonr","title":"Ekso Bionics Receives FDA Clearance for Multiple Sclerosis","sourceName":"ChronoScale"}],"notes":"EksoNR is FDA-cleared for stroke, SCI, acquired brain injury, and multiple sclerosis (first exoskeleton cleared for MS, June 2022). Deployed in 375+ rehabilitation centers worldwide with 200+ published articles. Q1 2026 revenue: Americas $1.55M, EMEA $0.55M, APAC $0.04M. Company disclosed going-concern warning in Q1 2026 10-Q. Pending Business Combination with Applied Digital Cloud (ChronoScale). Go-to-market partners include National Seating & Mobility, Bionic Prosthetics & Orthotics Group, and Ottobock Patient Care.","keyFacts":[{"label":"FDA clearances","value":"Stroke (2016), SCI T4-L5 and C7-T3 ASIA D, ABI (2020), MS (June 2022, K220988) — first exoskeleton cleared for MS rehab"},{"label":"Clinical scale","value":"375+ rehabilitation centers worldwide; 200+ published articles; 2,000+ patients across 185+ clinical studies"},{"label":"Americas revenue Q1 2026","value":"$1.55M (US $1.53M)"},{"label":"Going concern","value":"Q1 2026 10-Q discloses substantial doubt; cash funds operations into early Q3 2026; Business Combination with Applied Digital Cloud pending"},{"label":"Go-to-market partners","value":"National Seating & Mobility, Bionic Prosthetics & Orthotics Group, Ottobock Patient Care"}],"reviewNote":null,"exposureHours":null,"exposureBasis":null,"customerSegment":null,"scaleTier":null,"contractValueUsd":null,"contractValueBasis":null,"customerCompanyId":null,"customerExternalName":null,"createdAt":"2026-06-07T13:21:38.775Z","updatedAt":"2026-06-07T13:21:38.775Z","model":{"id":"a4a2491a-bfdd-4ba3-b370-771d234bc136","companyId":"c36c0cb6-a327-458b-94ec-288386588250","modelName":"EksoNR","slug":"ekso-nr","description":"Powered (motor-driven) lower-limb exoskeleton for clinical gait rehabilitation (stroke, spinal-cord injury, acquired brain injury). User intent plus weight-shift triggers powered steps; the device powers the joints, the clinician/patient sets the session. FDA cleared.","formFactor":"exoskeleton","maturityStage":"commercial","lifecycleState":"active","supersededByModelId":null,"specs":{"use":"medical rehab","control":"weight-shift + user intent triggers powered steps","powered":"yes (motor-driven)","regulatory":"FDA cleared","body_region":"lower-limb","availability":"commercial"},"manufacturerSerial":null,"reviewStatus":"reviewed","sources":[{"url":"https://en.wikipedia.org/wiki/Ekso_Bionics","title":"EksoNR","sourceName":"Wikipedia"},{"url":"https://www.eksobionics.com/","title":"Ekso Bionics (official)","sourceName":"Ekso Bionics (primary)"}],"aliases":["Ekso NR","Ekso GT"],"collisionRisk":"low","reviewNote":null,"manufacturerTermForTeleop":null,"createdAt":"2026-06-06T01:25:39.474Z","updatedAt":"2026-06-06T02:44:43.312Z","company":{"id":"c36c0cb6-a327-458b-94ec-288386588250","name":"Ekso Bionics","slug":"ekso-bionics","description":"Powered medical exoskeleton maker (founded 2005 as Berkeley ExoWorks). Lower-limb gait-rehabilitation exoskeletons; acquired the Indego product line from Parker Hannifin in early 2023.","status":"public (NASDAQ: EKSO)","founded":2005,"hq":"Richmond, California, USA","fundingTotal":null,"type":"hardware","reviewStatus":"reviewed","sources":[{"url":"https://en.wikipedia.org/wiki/Ekso_Bionics","title":"Ekso Bionics","sourceName":"Wikipedia"},{"url":"https://www.eksobionics.com/","title":"Ekso Bionics (official)","sourceName":"Ekso Bionics (primary)"}],"keyFacts":[],"aliases":["Ekso","Ekso Bionics Holdings"],"collisionRisk":"low","reviewNote":null,"createdAt":"2026-06-06T01:25:37.654Z","updatedAt":"2026-06-06T02:17:58.827Z"}},"version":null,"location":{"id":"aa8b9c05-c836-4021-801f-59801970401e","name":"United States","slug":"united-states","kind":"country","parentLocationId":null,"lat":null,"lng":null,"reviewStatus":"reviewed","aliases":["USA","US","United States of America"],"collisionRisk":"high","reviewNote":null,"createdAt":"2026-05-30T22:00:33.148Z","updatedAt":"2026-05-30T22:00:33.148Z"},"operator":null,"owner":null,"derived":{"trustTier":"unverified","currentPosture":null},"jsonLd":{"@context":"https://schema.org","@type":"Event","@id":"https://registry.deploy.report/deployments/ekso-nr-united-states","url":"https://registry.deploy.report/deployments/ekso-nr-united-states","name":"EksoNR at United States","identifier":"cbb9eca5-f3b7-4400-a536-a8b6c8b973f6","eventStatus":"https://schema.org/EventScheduled","location":{"@type":"Place","@id":"https://registry.deploy.report/locations/united-states","name":"United States"},"organizer":{"@type":"Organization","@id":"https://registry.deploy.report/companies/ekso-bionics","name":"Ekso Bionics"},"about":{"@type":"Product","@id":"https://registry.deploy.report/models/ekso-nr","name":"EksoNR"},"publisher":{"@id":"https://deploy.report/#organization"}},"framework_metadata":{"framework_schema_version":"0.1.0","verification_status":"verified","maturity_stage":"commercial","lifecycle_state":"active","architectural_position":{"cohort":"exoskeleton","sub_cohorts":[]},"within_cohort_verified_vs_claimed_pair":null,"cap_flags":[],"verification_depth":{"sources_count":2,"primary_source_types":["primary-company-ir"]}}}